ReturnTo Theme-Group-Choice | Onelevelup |
4C088 | MEDICINES CONTAINING PLANT SUBSTANCES | |
A61K36/00 -36/05;36/06@A;36/07-36/9068 |
A61K36/00-36/05;36/06@A;36/07-36/9068 | AA | AA00 PLANT SPORES AS THE ORIGIN OF ACTIVE COMPONENTS |
AA01 | AA02 | AA03 | AA04 | AA05 | AA06 | AA07 | AA08 | AA09 | |
. High Eumycetes | . . Basidiomycetes | . . . Tree-ears and white tree-ears | . . . Polyporaceae | . . . . Trametes versicolor | . . . . Ganoderma | . . . Agaricales campestris and Tricholoma magnivelare | . . . . Kishimeji | . . . . Amanita | ||||
AA11 | AA12 | AA13 | AA14 | AA15 | AA16 | AA17 | AA18 | AA20 | ||||
. Lichens | . Algae | . . Phaeophyceae | . . Rhodophyceae | . . Chlorophyceae | . . . Chlorella | . Bryophyta | . Pteridophyta (i.e., Polypodiophyta) | . Others | ||||
AB | AB00 SPERMATOPHYTES AS THE ORIGIN OF ACTIVE COMPONENTS |
AB01 | AB02 | AB03 | AB04 | |||||||
. Gymnospermae | . . Ginkgo biloba | . . Coniferales | . . Ephedra | |||||||||
AB11 | AB12 | AB13 | AB14 | AB15 | AB16 | AB17 | AB18 | AB19 | AB20 | |||
. Spermatophytes | . . Balsaminaceae: Impatiens balsamina. | . . . Malvaceae | . . . Rubiaceae | . . . Cruciferae | . . . Araliaceae | . . . . Japanese angelica-tree family | . . . . Tochiba-ninjin (i.e., ginseng) | . . . Cucurbitaceae | . . . . Hydrangea serrata | |||
AB21 | AB22 | AB23 | AB24 | AB25 | AB26 | AB27 | AB28 | AB29 | AB30 | |||
. . . Rhus verniciflua | . . . Plantago asiatica | . . . Valerianaceae | . . . Japanese persimmon-tree family | . . . Birch-tree family | . . . Compsitae | . . . . Thistle family | . . . . Michaelmas-daisy family | . . . . Artemisia indica | . . . Platycodon grandiflorum | |||
AB31 | AB32 | AB33 | AB34 | AB35 | AB36 | AB37 | AB38 | AB39 | AB40 | |||
. . . Oleander family | . . . Buttercup family | . . . Camphor tree family | . . . Mulberry family | . . . Papaveraceae | . . . Poppy family | . . . Pedaliaceae | . . . Perilla frutescens crispa | . . . Water lily family | . . . Petroselinum crispum | |||
AB41 | AB42 | AB43 | AB44 | AB45 | AB46 | AB47 | AB48 | AB49 | AB50 | |||
. . . . Angelica pubescens | . . . Meliaceae | . . . Polygonum | . . . Azalea family | . . . Camellia family | . . . Euphorbiaceae | . . . Saururaceae | . . . Solanaceae | . . . . Tobacco | . . . . Capsicum | |||
AB51 | AB52 | AB53 | AB54 | AB55 | AB56 | AB57 | AB58 | AB59 | AB60 | |||
. . . Rose family | . . . . Cherry-blossom family | . . . . Cydonia oblonga | . . . Polygala japonica | . . . Geraniaceae | . . . Grape family | . . . Myrtaceae | . . . Paeonia suffruticosa | . . . Leguminosae | . . . . Glycyrrhiza glabra | |||
AB61 | AB62 | AB63 | AB64 | AB65 | AB66 | AB67 | ||||||
. . . . Soybeans | . . . Rutaceae | . . . Japanese-barberry family | . . . Oleaceae Ligustrum, Fraxinus japonica, Osmanthus fragrans, Olea europaea, and others. | . . . Magnolia liliflora | . . . Saxifragaceae | . . . Gentiana makinoi | ||||||
AB71 | AB72 | AB73 | AB74 | AB75 | AB76 | AB77 | AB78 | AB79 | AB80 | |||
. . Monocotyledonous plants | . . . Iridaceae | . . . Grasses or Gramineae | . . . . Grasses | . . . . Avena fatua | . . . . Bamboo grass and Phyllostachys bambusoides | . . . . Coix lacryma-jobi | . . . . Corn | . . . Cyperaceae | . . . Colocasia antiquorum | |||
AB81 | AB82 | AB83 | AB84 | AB85 | AB86 | AB87 | AB88 | AB89 | ||||
. . . Zingiber officinale | . . . Amaryllidaceae | . . . Palm family | . . . Dioscorea japonica | . . . Liliaceae | . . . . Aloe | . . . . Green onions | . . . . . Garlic | . . . Orchid family | ||||
AB99 | ||||||||||||
. Others | ||||||||||||
AC | AC00 MEDICINAL PARTS OF PLANTS |
AC01 | AC02 | AC03 | AC04 | AC05 | AC06 | AC07 | AC08 | AC09 | AC10 | |
. All grasses and trees | . . Above-ground portions of plants | . . . Flowers | . . . Fruits and seeds | . . . Leaves and stems | . . . Xylem and branches | . . . Trichomes | . . . Resins and balsam | . . . Fungus gall and nutgall | . . Underground portions of plants | |||
AC11 | AC12 | AC13 | AC14 | AC15 | AC16 | AC17 | AC18 | AC20 | ||||
. . . Roots | . . . Subterranean stems | . . . . Rhizomes | . . Recycling of the material remaining after the primary use | . Fungi and algae | . . Mycobacteria and cultures | . . . Fruit bodies and mycelia | . . Spores and sclerotia | . Others | ||||
AD | AD00 MATERIALS OTHER THAN HIGHER PLANTS THAT ARE THE ORIGIN OF ACTIVE COMPONENTS |
AD01 | AD02 | AD03 | AD06 | AD07 | AD08 | AD09 | AD10 | |||
. Origins of inanimate objects | . . Water | . . Talcum and clay | . Animal origins | . . Annelida | . . Mollusca | . . Arthropods | . . . Honey, beeswax, and propolis | |||||
AD11 | AD12 | AD13 | AD14 | AD15 | AD16 | AD17 | AD18 | AD19 | AD20 | |||
. . Fishes | . . Amphibia and reptilia | . . Mammalia and birds | . . . Cattle and deer | . Microorganisms | . . Ascomycetes | . . . Yeasts | . . . Aspergillus | . . . Claviceps purpurea | . . . Imperfect fungi | |||
AD21 | AD22 | AD30 | ||||||||||
. . Bacteria | . . . Lactic-acid bacteria and acetic-acid bacteria | . Others | ||||||||||
BA | BA00 SEPARATE ACTIVE COMPONENTS |
BA01 | BA02 | BA03 | BA04 | BA05 | BA06 | BA07 | BA08 | BA09 | BA10 | |
. Inorganic active components | . Organic active components | . . Animal materials | . . Microorganism materials | . . . Water extracts from basidiomycetous substances and mycelia | . . Plant materials | . . . Smashed and crushed substances from plant bodies | . . . Extracts | . . . . Water extracts | . . . . Alcohol extracts | |||
BA11 | BA12 | BA13 | BA14 | BA15 | BA16 | BA17 | BA18 | BA19 | ||||
. . Active substances | . . . Saccharides | . . . . Glycosides | . . . . . Flavones | . . . . Liposaccarides | . . . Proteins and peptides | . . . . Glycoproteins These, which are a conjugated protein, are obtained through conjugation between the carbohydrate or its derivative and the protein. | . . . Lipids (i.e., fats and oils) | . . . Lignin, tannin, and lignin and tannin derivatives | ||||
BA21 | BA22 | BA23 | BA24 | BA25 | BA26 | BA27 | ||||||
. . Substances with defined property data and chemical structures | . . . Compounds with specific molecular weights (MW) | . . . . Molecular weights (MW) less than or equal to 1000 | . . . . Molecular weights greater than 1000 and less than or equal to 3000 | . . . . Molecular weights greater than 3000 and less than or equal to 10000 | . . . . Molecular weights greater than 10000 and less than or equal to 100000 | . . . . Molecular weights greater than 100000 | ||||||
BA31 | BA32 | BA33 | BA34 | BA35 | BA37 | BA40 | ||||||
. . . Compounds with defined molecular formulas and overall chemical structures | . . . . Constituent elements that contain carbon (C), hydrogen (H), and oxygen (O) | . . . . Constituent elements that contain carbon (C), hydrogen (H), oxygen (O), and nitrogen (N) | . . . . Constituent elements that contain carbon (C), hydrogen (H), oxygen (O), and sulfur (S) | . . . . Constituent amino acids for which the sequence or composition is defined | . . Substances without defined property data | . Others | ||||||
CA | CA00 MEANS FOR SEPARATION, REFINEMENT, AND STABILIZATION OF ACTIVE COMPONENTS |
CA01 | CA02 | CA03 | CA04 | CA05 | CA06 | CA07 | CA08 | CA09 | CA10 | |
. Mechanical and physical processing | . . Heating, cooling, and pressurization | . . Extraction | . . . Hydrophilic solvents | . . . . Water only | . . . . Lower alcohols | . . . . Esters and ketones | . . . . Mixed solvents with water and organic solvents | . . . Extraction by hydrophobic solvents | . . . Supercritical extraction methods | |||
CA11 | CA12 | CA13 | CA14 | CA15 | CA16 | CA17 | CA18 | CA19 | ||||
. . Concentration, drying, and freezing | . . Centrifugal separation and solid-liquid separation | . . Adsorption and adhesion | . . . Chromatography processes | . . Distillation | . . Dialysis and salting-out | . . Filtration and membrane processing | . . Swelling and expansion processing | . . Crystallization, granulation, and sedimentation | ||||
CA21 | CA22 | CA23 | CA24 | CA25 | CA26 | CA28 | CA30 | |||||
. Chemical treatments | . . Hydrolysis | . . Neutralization and pH adjustment | . . Oxidation and reduction | . . Fermentation, culturing, and enzyme treatment | . . Chemical treatment by use of additives or formation of complexes | . Processing using stabilization and addition agents | . Others | |||||
MA | MA00 COMBINATION, FORMS, AND APPLICATION MODES OF AGENTS |
MA01 | MA02 | MA03 | MA04 | MA05 | MA06 | MA07 | MA08 | MA09 | ||
. Combination agents | . . Agents containing single plant components and organic active components | . . . Agents containing single plant components and vitamins | . . . Agents containing single plant components and saccharides | . . . Agents containing single plant components and synthetic macromolecular materials | . . Agents containing single plant components and inorganic active components | . . Agents containing multiple plant components | . . . Agents containing multiple plant components and organic active components | . . . Agents containing multiple plant components and inorganic active components | ||||
MA11 | MA12 | MA13 | MA16 | MA17 | ||||||||
. Forms | . . Gases | . . . Aerosols and foamed agents | . . Liquids | . . . Solutions | ||||||||
MA21 | MA22 | MA23 | MA24 | MA27 | MA28 | |||||||
. . . Liquid dispersion agents | . . . . Emulsifiers | . . . . Suspension agents | . . . . Ribosomes | . . Semi-solids | . . . Creams, pastes, and ointments | |||||||
MA31 | MA32 | MA34 | MA35 | MA36 | MA37 | MA38 | ||||||
. . . Suppositories and bougies | . . . Pasting agents | . . Solids | . . . Pills for oral intake | . . . Pellets | . . . Capsules | . . . . Microcapsules | ||||||
MA41 | MA43 | MA44 | MA47 | |||||||||
. . . Granular agents | . . . Powdered agents | . . . . Freeze-dried powders | . . . Gum | |||||||||
MA51 | MA52 | MA55 | MA56 | MA57 | MA58 | MA59 | MA60 | |||||
. Application modes | . . Oral intake | . . Nonoral application | . . . Body cavities and mucous membranes | . . . . Oral cavity | . . . . Eyes | . . . . Nasal cavities | . . . . Rectum | |||||
MA63 | MA65 | MA66 | MA67 | MA70 | ||||||||
. . . Skin and epidermis | . . . Blood vessels and tissue | . . . . Injection, delivery of liquids, and intravenous drips | . . . . Internal implantation | . Others | ||||||||
NA | NA00 PURPOSE AND EFFECTS OF SUBSTANCES, OR MIXED OR PELLATIZED SUBSTANCES |
NA01 | NA02 | NA03 | NA04 | NA05 | NA06 | NA07 | NA08 | NA09 | NA10 | |
. Virus deactivation | . Solubilization | . Stabilization | . Timing adjustment | . Improvement of effectivess and effectiveness of selectivity | . Reduction of side effects | . Reduction of toxicity | . Reduction of pain | . Improvement of taste and odor | . Change of dosing mode | |||
NA11 | NA12 | NA13 | NA14 | NA15 | NA20 | |||||||
. Improvement of absorption | . Gradual release and effectiveness of release time | . Internal delivery of medications | . Expression of new medicinal effects | . Pro-drug effects | . Others | |||||||
ZA | ZA00 MEDICAL APPLICATIONS AND ORGANS |
ZA01 | ZA02 | ZA03 | ZA04 | ZA05 | ZA06 | ZA07 | ZA08 | |||
. Medicines that act on the nervous system | . . Central nervous system | . . . Central-nervous-system inhibitors | . . . . General anesthetics | . . . . Hypnotic agents and tranquilizers | . . . . Anti-epilepsy medications | . . . . Antifebriles | . . . . Pain-killers | |||||
ZA11 | ZA12 | ZA14 | ZA15 | ZA16 | ZA18 | ZA20 | ||||||
. . . Central-nervous-system stimulants | . . . . Antidepressants | . . . Sedatives | . . . Medications that improve of brain function | . . . . Medications for treating Alzheimer's disease | . . . Medicines for treatment of psychoneurosis | . . Medicines for the peripheral nervous system | ||||||
ZA21 | ZA22 | ZA23 | ZA24 | ZA25 | ZA26 | ZA27 | ZA28 | ZA29 | ZA30 | |||
. . . Medications for the sensory nerves | . . . Medications for the motor nerves | . . . . Skeletal-muscle relaxants | . . . Medications for the autonomic nervous system | . . . . Sympathetic-nerve stimulants | . . . . Sympathetic-nerve inhibitors | . . . . Parasympathetic-nerve stimulants | . . . . Parasympathetic-nerve inhibitors | . . . . Anticonvulsants | . . . . Diaphoretics and anti-perspirants | |||
ZA31 | ZA32 | ZA33 | ZA34 | ZA36 | ZA37 | ZA38 | ZA39 | ZA40 | ||||
. Medicines that act on specific organs | . . Medicines for the sensory organs | . . . Ophthalmologic medications | . . . Otorhinologic medications | . . Medicines for the organs of the circulatory system | . . . Myocardial stimulants | . . . Myocardial inhibitors | . . . Vasodilators | . . . . Coronary vasodilators | ||||
ZA41 | ZA42 | ZA43 | ZA44 | ZA45 | ||||||||
. . . Vasoconstrictors | . . . Hypotensive medications | . . . Hypertensive medications | . . . Agents for reinforcing the blood vessels | . . . Medications to combat arteriosklerosis | ||||||||
ZA51 | ZA52 | ZA53 | ZA54 | ZA55 | ZA59 | ZA60 | ||||||
. . Medicine for hematogenous organs (i.e., bone marrow, blood, and body fluids) | . . . Blood substitutes | . . . Hemostatics and coagulants | . . . Anti-coagulants and thrombus-dissolving medications | . . . Medications to combat anemia | . . Medicines for organs of the respiratory system | . . . Breathing accelerators | ||||||
ZA61 | ZA62 | ZA63 | ZA66 | ZA67 | ZA68 | ZA69 | ZA70 | |||||
. . . Bronchial vasodilators | . . . Antitussives | . . . Expectorants | . . Medicines for organs of the digestive tract | . . . Medications for the oral cavity | . . . Medications to treat ulcers in the digestive tract | . . . Medications for the peptic digestive tract | . . . Anti-obesity medications | |||||
ZA71 | ZA72 | ZA73 | ZA75 | ZA76 | ZA77 | |||||||
. . . Medications to suppress or induce vomiting | . . . Antidiarrheals | . . . Medications for intestinal disorders | . . . Medications to treat the liver and bile-duct systems | . . . . Biliary medications | . . . . Medications to dissolve gallstones | |||||||
ZA81 | ZA82 | ZA83 | ZA84 | ZA85 | ZA86 | ZA89 | ZA90 | |||||
. . Medicines for organs of the urogenital tract and the rectum | . . . Bactericides for the bladder | . . . Diuretics | . . . Anti-diuretics | . . . Medications to induce uterine contractions | . . . Contraceptive agents | . . Medicines for the epidermis | . . . Skin cleaners | |||||
ZA91 | ZA92 | ZA94 | ZA96 | ZA97 | ||||||||
. . . Skin softeners | . . . Medicines for the scalp and hair | . . Medicines for the muscular system | . . Medicines for the skeletal system | . . . Medications for osteoporosis | ||||||||
ZB | ZB00 MEDICAL APPLICATIONS AND THE IMMUNE SYSTEM |
ZB01 | ZB02 | ZB03 | ZB05 | ZB07 | ZB08 | ZB09 | ||||
. Medicines specifically for boosting the body's protective system | . . Medicines for the cellular immune system | . . . Agents that induce production of interferon | . . Medicines for the immune defenses in body fluids | . . Medicines for adjustment of immunity | . . Immunity inhibitors | . . Immunity accelerators | ||||||
ZB11 | ZB13 | ZB15 | ||||||||||
. . Medicines to control inflammation | . . Medicines to treat allergies | . . Medicines to combat rhematism | ||||||||||
ZB21 | ZB22 | ZB26 | ZB27 | |||||||||
. Medicines to boost cellular function in tissue | . . Medicines for cellular stimulation | . . Medicines to combat tumors | . . . Medicines to treat leukemia | |||||||||
ZB31 | ZB32 | ZB33 | ZB35 | ZB37 | ZB38 | ZB39 | ||||||
. Medicines that attack pathogenic organisms | . . Medicines that attack pathogenic microorganisms | . . . Anti-viral agents | . . . Antibacterial agents | . . Medicines to combat parasites | . . . Anti-protozoan medications | . . . Vermicides | ||||||
ZC | ZC00 MEDICAL USES, FUNCTIONS, ACTIVITY, OBJECTS, AND OTHERS |
ZC01 | ZC02 | ZC03 | ZC04 | ZC06 | ZC08 | ZC10 | ||||
. Medicines working specifically on the body's functions | . . Medicines for physiologically active substances in living bodies | . . . Hormone-like medications | . . . . Medicines similar to pituitary hormones | . . . . Medicines similar to thyroid and parathyroid hormones | . . . . Medicines similar to paranephric hormones | . . . . Medicines similar to male hormones | ||||||
ZC11 | ZC12 | ZC13 | ZC14 | ZC16 | ZC17 | ZC19 | ZC20 | |||||
. . . . Medicines similar to female hormones | . . . Prostaglandin-like agents | . . . Antihistamines | . . . Anti-seratonin agents | . . . Bradykinin-like medicines | . . . Angiotensin-like medicines | . . . Enzyme-activating agents | . . . Enzyme inhibitors | |||||
ZC21 | ZC22 | ZC23 | ZC24 | ZC25 | ZC26 | ZC28 | ZC29 | |||||
. . Metabolic medicines | . . . Vitamins | . . . . Vitamins A and D | . . . . Vitamin B | . . . . . Vitamin B1 | . . . . . Vitamin B2 | . . . . Vitamins C and P | . . . . Vitamins E and K | |||||
ZC31 | ZC33 | ZC35 | ZC37 | ZC39 | ||||||||
. . . Medicines affecting uric-acid metabolism | . . . Medicines affecting lipid metabolism | . . . Medicines affecting saccharide metabolism | . . . Antitoxins | . . . Medicines to treat addiction | ||||||||
ZC41 | ZC42 | ZC43 | ZC44 | ZC45 | ZC48 | ZC50 | ||||||
. Medicines with specific action | . . Receptor antagonists | . . . Beta blockers | . . . Histamine-2 blockers | . . . Histamine-1 blockers | . . Platlet-activating factor (PAF) antagonists | . . Calcium antagonists | ||||||
ZC51 | ZC52 | ZC54 | ZC55 | |||||||||
. Specific medicines for specific treatment purposes | . . Medicines for geriatric diseases | . . Medicines specific to particular symptoms and diseases | . . . Medications for acquired immune-deficiency syndrome (AIDS) | |||||||||
ZC61 | ZC62 | ZC63 | ZC64 | ZC65 | ||||||||
. . Medicines for animals | . . . Medications for treating udder inflammation | . . . Medications to induce milk production | . . . Medications for treating coccidiosis | . . . Medications for poikilotherms | ||||||||
ZC71 | ZC72 | ZC75 | ZC78 | ZC80 | ||||||||
. Medicines relating to physical therapy | . . Medicine for moxibustion therapy | . Synergistic medicines | . Analysis reagents and detection reagents | . Others or indefinite materials |